Related Experiment Videos
Extinction of the weakest.
1Department of Radiation Oncology, Newcastle University, Newcastle Mater Misericordiae Hospital, Waratah, New South Wales, Australia. mdjwd@alinga.newcastle.edu.au
International Journal of Radiation Oncology, Biology, Physics
|November 8, 2001
Summary
Tumor cell doubling time in head-and-neck cancer radiotherapy decreases during treatment, potentially linked to cellular depletion. This suggests repopulation is best modeled by a continuously reducing doubling time.
Area of Science:
- Radiation Oncology
- Cancer Biology
- Tumor Kinetics
Background:
- Tumor cell repopulation is a critical factor influencing radiotherapy outcomes in head-and-neck cancer.
- Understanding changes in tumor cell doubling time during treatment is essential for optimizing radiation regimens.
Purpose of the Study:
- To investigate the relationship between accumulating radiation dose and changes in the effective doubling time of head-and-neck cancer cells.
- To evaluate different models describing tumor cell proliferation dynamics during radiotherapy.
Main Methods:
- Analysis of data from three randomized controlled trials (CHART, RTOG 90-03, TROG 91.01) using iso-effective regimens.
- Comparison of 'fixed response time' models with 'cellular depletion' models linking doubling time changes to cumulative biologic dose.
Main Results:
- Effective tumor cell doubling time decreases continuously during radiotherapy for head-and-neck cancer.
- Models incorporating cellular depletion provided a satisfactory fit to the observed data.
- The effective doubling time was found to reduce to approximately 2 days during high-dose curative regimens.
Conclusions:
- The 'repopulation phenomenon' in head-and-neck cancer radiotherapy may be best represented by a continuously decreasing effective tumor cell doubling time.
- This reduction in doubling time appears to be associated with cellular depletion within the tumor.
- Findings support the development of radiotherapy strategies that account for dynamic changes in tumor cell proliferation.